Biolife solutions stock.

Nov 30, 2023 · BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company’s products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. BioLife Solutions Inc stock performance at a glance. Check BioLife Solutions Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.In today’s fast-paced world, it can be challenging to stay organized and manage our time effectively. With so many tasks and responsibilities vying for our attention, it’s crucial to have a reliable tool that can help us stay on track. This...BOTHELL, Wash., July 2, 2020 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today announced the pricing of its public offering of 5,175,000 shares of its common stock at a public offering price of $14.50 per share, before underwriting ...

intraday 1w 1m 6m ytd 1y 3y 5y max Mountain-Chart Compare with Compare with up to 5 Stocks On Wednesday 11/08/2023 the closing price of the Biolife …The estimated net worth of Aby J. Mathew is at least $3.52 million as of November 13th, 2023. Dr. Mathew owns 275,726 shares of BioLife Solutions stock worth more than $3,521,021 as of November 18th. This net worth estimate does not reflect any other assets that Dr. Mathew may own.

BioLife Solutions is a class-defining cell and gene therapy bioproduction tools and services company. Our solutions give life science companies and clinical researchers significant improvement in shelf life and post-preservation viability and function of biological materials. BioLife Solutions is one of Washington’s best places to work ...

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 10.89% during the next 3 months and, with a 90% probability hold a price between $0.00000328 and $0.0002 at the end of this 3-month period.BioLife Solutions is expected to report its next quarterly earnings on March 12, 2020. TrendSpider From a technical standpoint, the stock opened higher and closed sharply lower during Thursday's ...The estimated net worth of Aby J. Mathew is at least $3.52 million as of November 13th, 2023. Dr. Mathew owns 275,726 shares of BioLife Solutions stock worth more than $3,521,021 as of November 18th. This net worth estimate does not reflect any other assets that Dr. Mathew may own.Get the latest BioLife Solutions Inc (BLFS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment …

BOTHELL, Wash., Aug. 8, 2023 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading supplier of class-defining bioproduction tools and services for the cell ...

Stock analysis for BioLife Solutions Inc (BLFS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Press Releases. BioLife Solutions Reports First Quarter 2023 Financial Results. Revenue of $37.7 million increased 4% over Q1 2022, ex-COVID growth of 16% and biopreservation media revenue growth of 28%. Q1 2023 Adjusted gross margin improvement; 37% compared to 32% in Q4 2022. Decision to Explore Strategic Alternatives for Ultra-Low ...Safely store valuable samples at ultra-low temperatures from -20°C to -86°C. The ULT25NEU holds 18 2-inch boxes in a portable and lightweight 25-liter (0.9 cu. ft.) size, made possible by our breakthrough ULT technology. Designed for space and energy efficiency, the ULT25NEU ultra-low temperature freezer uses less than 2.8 kWh/day at …Nov 28, 2023 · BioLife Solutions, Inc. is a life sciences company. The Company develops, manufactures, and markets bioproduction tools and services which are designed to de-risk biologic manufacturing, storage ... Chief Quality Officer Of Biolife Solutions Trades $760K In Company Stock. (Benzinga) Sep-20-21 08:00AM. BioLife Solutions Appoints Joydeep Goswami, MBA, PhD to Board of Directors. (PR Newswire) BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings ...BioLife Solutions Inc stock performance at a glance. Check BioLife Solutions Inc’s past financial performance, like revenue or net income, plus the top level summary of its past …If this sounds like the kind of workplace you would thrive in, please have a look at our current openings and apply! Perks of working at BioLife Solutions include: At-market competitive wages. Affordable, high-quality medical, dental and vision insurance for team members and their dependents. 401k matching program. Generous company stock awards.

Nov 27, 2023 · BioLife Solutions Stock Performance. BLFS stock opened at $14.08 on Monday. The business has a 50 day moving average of $12.13 and a 200-day moving average of $16.47. BioLife Solutions, Inc. has a 12-month low of $8.92 and a 12-month high of $26.89. The firm has a market cap of $619.96 million, a PE ratio of -5.94 and a beta of 1.57. BOTHELL, Wash., Nov. 4, 2021 / PRNewswire / -- BioLife Solutions, Inc. (the "Company") (Nasdaq: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced changes to its executive management team, effective immediately.(RTTNews) - Today's Daily Dose brings you news about FDA panel's stance on Akcea's drug candidate for a rare lipid disorder called familial chylom...Dec 1, 2023 · View BioLife Solutions, Inc BLFS investment & stock information. Get the latest BioLife Solutions, Inc BLFS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. BioLife Solutions Stock Up 7.1 %. Shares of NASDAQ BLFS opened at $13.25 on Monday. BioLife Solutions, Inc. has a one year low of $8.92 and a one year high of $26.89. The company has a debt-to ...Broadridge Corporate Issuer Solutions, Inc. P.O. Box 1342 Brentwood, New York 11717 USA (877) 830 - 4936 [email protected]

Nov. 4, 2021, 04:05 PM. BOTHELL, Wash., Nov. 4, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (the "Company") (Nasdaq: BLFS), a leading supplier of class-defining bioproduction tools and services ...

Nov 9, 2022 · BioLife Solutions, Inc. (BLFS) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to break-even earnings per share a year ago ... Maximize post-thaw cell recovery and viability following cryopreservation at low temperatures (-80°C to -196°C) with ready-to-use CryoStor® CS5. Serum-free, animal component-free, and cGMP-manufactured, this defined medium provides a safe, protective environment for cells and tissues during freezing and thawing processes and storage.--BioLife Solutions, Inc., ... BioLife will issue 6,646,870 shares of common stock for 100% of the outstanding shares of Stirling in an all-stock transaction, which is expected to close early in ...With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.CryoStor®CS10 effectively mitigates temperature-induced molecular cell stress responses to maximize post-thaw viability and recovery for a variety of immune cell types, including T cells (data not shown) and B cells. Here, human B cells from 6 different donors cryopreserved in CryoStor®CS10 show reproducibly high viability after thawing, as ...Jan 6, 2023 · While BioLife Solutions, Inc. ( NASDAQ:BLFS) might not be the most widely known stock at the moment, it saw significant share price movement during recent months on the NASDAQCM, rising to highs ... On average, Wall Street analysts predict. that Biolife Solutions's share price could reach $25.50 by Aug 10, 2024. The average Biolife Solutions stock price prediction forecasts a potential upside of 103.84% from the current BLFS share price of $12.51.We are revolutionizing regenerative medicine, biobanking and drug discovery by increasing the viability of biologics. BioLife Solutions is a class-defining cell and gene therapy bioproduction tools and services company. Our solutions give life science companies and clinical researchers significant improvement in shelf life and post-preservation ...The estimated net worth of Roderick de Greef is at least $463,582.14 as of November 30th, 2022. Mr. de Greef owns 34,314 shares of BioLife Solutions stock worth more than $463,582 as of November 20th. This net worth estimate does not reflect any other investments that Mr. de Greef may own.

CryoStor®CS10 effectively mitigates temperature-induced molecular cell stress responses to maximize post-thaw viability and recovery for a variety of immune cell types, including T cells (data not shown) and B cells. Here, human B cells from 6 different donors cryopreserved in CryoStor®CS10 show reproducibly high viability after thawing, as ...

Stock analysis for BioLife Solutions Inc (BLFS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

BioLife Solutions, Inc. is a life sciences company. The Company develops, manufactures, and markets bioproduction tools and services which are designed to de-risk biologic manufacturing, storage, distribution, and transportation in the cell and gene therapy (CGT) industry and broader biopharma markets.Get in touch. BioLife Solutions Inc. 3303 Monte Villa Parkway, Suite 310, Bothell , WA 98021 USA. For assistance, please call us Monday through Friday (9:00 am to 5:00 pm PST) at:Mar 22, 2021 · With Stirling, BioLife believes that total GAAP revenue in 2021 will exceed $100 million and the transaction is expected to be accretive on an adjusted Net Income per share basis (Non-GAAP) in ... Chief Quality Officer Of Biolife Solutions Trades $760K In Company Stock. (Benzinga) Sep-20-21 08:00AM. BioLife Solutions Appoints Joydeep Goswami, MBA, PhD to Board of Directors. (PR Newswire) BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings ...CryoStor®CS10 effectively mitigates temperature-induced molecular cell stress responses to maximize post-thaw viability and recovery for a variety of immune cell types, including T cells (data not shown) and B cells. Here, human B cells from 6 different donors cryopreserved in CryoStor®CS10 show reproducibly high viability after thawing, as ...BOTHELL, Wash., Aug. 9, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that it has entered into a definitive agreement to acquire all remaining outstanding shares of privately held Sexton ...In today’s fast-paced world, it can be challenging to stay organized and manage our time effectively. With so many tasks and responsibilities vying for our attention, it’s crucial to have a reliable tool that can help us stay on track. This...Historical daily share price chart and data for BioLife Solutions since 1992 adjusted for splits and dividends. The latest closing stock price for BioLife Solutions as of …/PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), ... for $24.0 million, in consideration for 506,382 newly issued shares of BioLife common stock. Taking into ...BOTHELL, Wash., Aug. 9, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that it has entered into a definitive agreement to acquire all remaining outstanding shares of privately held Sexton ...Sep 1, 2021 · BOTHELL, Wash., Sept. 1, 2021 / PRNewswire / -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that it has closed its acquisition of Sexton Biotechnologies ... BOTHELL, Wash., May 2, 2023 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's first quarter financial results will be released after market close on Wednesday, May 10, 2023.

Biolife Solutions will release earnings for Q1 on May 10. Wall Street predict expect Biolife Solutions will release losses per share of $0.213. Go here to watch Biolife Solutions stock price in ...intraday 1w 1m 6m ytd 1y 3y 5y max Mountain-Chart Compare with Compare with up to 5 Stocks On Wednesday 11/08/2023 the closing price of the Biolife …BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company’s products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies.Instagram:https://instagram. top accelerators in silicon valleycrowdfunding real estate developmentfirstfinwilshire5000 Dec 1, 2023 · View BioLife Solutions, Inc BLFS investment & stock information. Get the latest BioLife Solutions, Inc BLFS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. May 19, 2023 · Shareholder Director Nominations. The Board of Directors of BioLife Solutions, Inc., a Delaware corporation, (the " Company ") determined that the Company's 2023 Annual Meeting of Stockholders (the " Annual Meeting ") will be held on July 21, 2023. It is expected that the Annual Meeting will be held virtually on the internet, but the time and ... when do iphone preorders startbest chinese stock BioLife Sciences is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. 2831 Saint Rose Parkway Suite 200 Henderson, NV 89052 United StatesWhen it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll want to ensure that you find the best one available in stock. best buy medical Nov 27, 2023 · BioLife Solutions Stock Performance. BLFS stock opened at $14.08 on Monday. The business has a 50 day moving average of $12.13 and a 200-day moving average of $16.47. BioLife Solutions, Inc. has a 12-month low of $8.92 and a 12-month high of $26.89. The firm has a market cap of $619.96 million, a PE ratio of -5.94 and a beta of 1.57. The business earned $33.33 million during the quarter, compared to the consensus estimate of $33.28 million. BioLife Solutions has generated ($2.37) earnings per share over the last year (($2.37) diluted earnings per share). Earnings for BioLife Solutions are expected to grow in the coming year, from ($1.06) to ($0.26) per share.